Everyone
Deserves
Clean Climate
TruuSome will always strive to leave a greener future for us and the planet. We will let the numbers talk for us. 29,892-acre land footprint saved. 176,152 litres of water saved. 1,48,552 kilograms of CO2 emissions saved. And we are just getting started here!
A huge green thumb!
We take immense care in making sure our product life cycle is sustainable and scalable in a way that never would impact the environment around us negatively. By sourcing our materials for local producers, re-defining our production techniques to minimize wastage of resources to not using plastics in packaging we take our green thumb seriously.
Removing need on Animals
We understand the phrase live and let live perfectly. Our product provides better nutrition and vitamins as compared to many non-vegetarian options. Furthermore, it is easier to integrate into your current diet rather than making a mess cooking salmon. So why not?
AI as the nutrional chemist
We use AI to find the most effective way to deliver you the essential micronutrients and vitamins in a safe and efficient way. Our algorithms parse through tons of ingredients to confirm the best brew to deliver on our promises.
Welcome!
As of August 19, 2023, our proprietary algorithm and formulation have been sold to Orion Pharmaceuticals & Nutraceuticals (India). Under the terms of the agreement, Orion Pharmaceuticals & Nutraceuticals (India) will retain exclusive access to this technology atleast for next 5 years(further changes subject to mutual agreement). After this period, the algorithm and formulation will be made open-source. This website displays a static version of our earlier site, as some information has been withheld due to confidentiality clauses in the buyout agreement. If you're interested in the future open-source release, please contact us via WhatsApp to express your interest. Click on our Old Chatbot Box to connect with us on WhatsApp.
Hello! This is no longer an interactive chatbot. Use the button below to contact us on WhatsApp if you're interested in accessing our open-source algorithm for drug development after the exclusivity period.
